Кветмолимаб

Rec. INN (наименование, зарегистрированное ВОЗ)

USAN (наименование, принятое к употреблению в США)

84585474

2084037-83-0

immunoglobulin G2-kappa, anti-[Homo sapiens CX3CL1 (chemokine C-X3-C motif ligand 1, SCYD1, small inducible cytokine subfamily D Cys-X3- Cysmember 1, fractalkine, FKN, neurotactin, NTN)], monoclonal antibody;
gamma2 heavy chain (1-445) [VH (Mus musculus IGHV1S56*01 (80.4%) -(IGHD) -IGHJ2*01 (93.3%)/Homo sapiens IGHV1-46*01 (76.3%) -(IGHD) -IGHJ4*01 (93.3%)) [8.8.12] (1-119) -Homo sapiens IGHG2*01 (CH1 (120-217), hinge (218-229), CH2 V1.2>A (233), G1>A (235) (230-338), CH3 (339-443), CHS (444-445)) (120-445)], (133-214')-disulfide with kappa light chain (1'-214') [V-KAPPA (Homo sapiens IGKV1-NL1*01 (85.3%) -IGKJ4*01 (100%)) [6.3.9] (1'- 107') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; dimer (221-221'':222- 222'':225-225":228-228")-tetrakisdisulfide

C₆₄₃₈H₉₈₇₀N₁₆₉₈O₂₀₀₆S₄₈

144690,5474 г/моль

Поделиться этой страницей